SCHEMBL135808

SCHEMBL135808

Cc1ccc(C(=O)c2c(N)sc3c2CCC2(C3)OCCO2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
GABRP O00591 7/20 0.45
GABRD O14764 7/20 0.45
GABRA1 P14867 7/20 0.45
GABRB1 P18505 7/20 0.45
GABRG2 P18507 7/20 0.45
GABRB3 P28472 7/20 0.45
GABRA5 P31644 7/20 0.45
GABRA3 P34903 7/20 0.45
GABRA2 P47869 7/20 0.45
GABRB2 P47870 7/20 0.45
GABRA4 P48169 7/20 0.45
GABRE P78334 7/20 0.45
GABRA6 Q16445 7/20 0.45
GABRG1 Q8N1C3 7/20 0.45
GABRG3 Q99928 7/20 0.45
GABRQ Q9UN88 7/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5457757 0.80 PTPN1 (0.54) PTPN1GABRPGABRDGABRA1GABRB1
SCHEMBL10274545 0.80 PTPN1 (0.64) PTPN1GABRPGABRDGABRA1GABRB1
SCHEMBL9095871 0.79 ALDH1A1 (0.46) PTPN1TDP1GABRPGABRDGABRA1
SCHEMBL2086919 0.78 GABRP (0.66) PTPN1TDP1GABRPGABRDGABRA1
SCHEMBL135906 0.77 TDP1 (0.50) PTPN1TDP1ALDH1A1MAPTLMNA
SCHEMBL136844 0.76 TDP1 (0.74) TDP1ALDH1A1MAPTLMNAGAA
SCHEMBL133029 0.76 TDP1 (0.70) TDP1ALDH1A1MAPTLMNAGAA
SCHEMBL30988084 0.75 GABRP (0.48) PTPN1GABRPGABRDGABRA1GABRB1
SCHEMBL30988100 0.75 HSD17B10 (0.60) PTPN1TDP1GABRPGABRDGABRA1
SCHEMBL135846 0.75 TDP1 (0.72) TDP1ALDH1A1MAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430029-B1 THIENO[2,3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS UNIV LEUVEN KATH (BE) 2018-01-10 EP disclosed
US-9499563-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-11-22 US disclosed
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS CISTIM LEUVEN VZW (BE) 2014-10-02 US disclosed
US-8785638-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-07-22 US disclosed
EP-2430029-A1 THIENO [2, 3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven (BE) 2012-03-21 EP disclosed
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-03-08 US disclosed
WO-2010130842-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS PTPN1 2792/4885TDP1 928/4885GABRP 2973/4885
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS PTPN1 2792/4885TDP1 928/4885GABRP 2973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.